Expression of Cyclooxygenase-2(COX-2) in Cancer Tissues of Early Stage Invasive Cervical Squamous Cell Carcinoma
Gu Zhang
Abstract
Gu Zhang
Abstract
[Purpose] To explore the clinical significance of cyclooxygenase-2(COX-2) expression in tumor tissues of 158 cases with early stage cervical squamous cell carcinoma. [Methods] Immunohistochemical assay (EnVision method) was used to detect COX-2 in all specimens,including 158 invasive cervical squamous cell carcinoma and 100 normal cervices. [Results] The overall positive expression rate of COX-2 in cervical cancer (55.70%,88/158) was higher than that in normal cervix(0/100)(χ2=84.527,P=0.000). In univariate survival analysis,positive COX-2 expression related to staging,deep stromal invasion and lymph vascular space involvement (P 0.05). The intensity of expression of COX-2 in cervical cancer did not relate to age,lymph node metastasis,occurrence/metastasis,tumor differentiation and tumor size(P0.05). [Conclusion] Postoperative adjuvant treatment should be considered for the cases of COX-2 positive expression with early stage cervical squamous cell carcinoma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Purpose] To explore the clinical significance of cyclooxygenase-2(COX-2) expression in tumor tissues of 158 cases with early stage cervical squamous cell carcinoma. [Methods] Immunohistochemical assay (EnVision method) was used to detect COX-2 in all specimens,including 158 invasive cervical squamous cell carcinoma and 100 normal cervices. [Results] The overall positive expression rate of COX-2 in cervical cancer (55.70%,88/158) was higher than that in normal cervix(0/100)(χ2=84.527,P=0.000). In univariate survival analysis,positive COX-2 expression related to staging,deep stromal invasion and lymph vascular space involvement (P 0.05). The intensity of expression of COX-2 in cervical cancer did not relate to age,lymph node metastasis,occurrence/metastasis,tumor differentiation and tumor size(P0.05). [Conclusion] Postoperative adjuvant treatment should be considered for the cases of COX-2 positive expression with early stage cervical squamous cell carcinoma.
Key concepts: Medicine, Stage (stratigraphy), Immunohistochemistry, Cyclooxygenase, Cervical cancer, Pathology, Stromal cell, Oncology